28 Jul 2016 15:18
Results of AGM
Immunodiagnostic Systems Holdings PLC 28 July 2016
28 July 2016
Immunodiagnostic Systems Holdings plc
Results of AGM
Immunodiagnostic Systems Holdings PLC ("the Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, announces the results of its Annual General Meeting (the "Meeting") that was held at 12 noon today.
Trading Update
At the meeting the Chairman, Dr Burkhard Wittek, provided a business update at the Meeting and a copy of the statement has been made available on the Company's website.
Voting Results
All resolutions put to the Meeting were decided on a show of hands and all were duly passed.
For information, details of the proxy voting are shown below:
Resolution | Votes For | Votes For (as % of votes cast) | Votes Against (as % of votes cast) | Votes Withheld |
1. To receive the accounts for the year ended 31 March 2016 together with the report of the Directors and of the Auditor thereon. | 13,731,734 | 100% | 0 | 0 |
2. To declare a final dividend for the year ended 31 March 2016. | 13,731,734 | 100% | 0 | 0 |
3. To elect as a director of the Company Mr Paul James Martin. | 13,730,148 | 99.99% | 0.01% | 0 |
4. To elect as a director of the Company Dr Klaus Peter Kaspar. | 13,730,148 | 99.99% | 0.01% | 0 |
5. To elect as a director of the Company Mr Roland Sackers. | 13,730,148 | 99.99% | 0.01% | 0 |
6. To elect as a director of the Company Mr Till Campe. | 13,726,648 | 99.96% | 0.04% | 0 |
7. To re-appoint Ernst & Young LLP as Auditor of the Company. | 13,730,148 | 99.99% | 0.01% | 0 |
8. To authorize the Directors of the Company to determine the remuneration of the Auditor of the Company. | 13,731,734 | 100% | 0 | 0 |
9. To approve the Directors' Remuneration Report for the financial year ended 31 March 2016. | 13,724,798 | 99.95% | 0.05% | 50 |
10. To authorise the Directors to allot relevant securities. | 13,730,148 | 99.99% | 0.01% | 0 |
11. To authorise the disapplication of pre-emption rights in accordance with section 570 of the Companies Act 2006. | 13,716,734 | 99.89% | 0.11% | 0 |
12. To authorise the Directors to make market purchases. | 13,731,734 | 100% | 0 | 0 |
The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the IDS website (www.idsplc.com).
For further information:
Immunodiagnostic Systems Holdings plc Tel : +44 (0)191 5190660
Patricio Lacalle, Chief Executive Officer
Paul Martin, Group Finance Director
Peel Hunt LLP Tel : +44 (0)207 418 8900
James Steel
Oliver Jackson